Traditionally, stimulation with pentagastrin was used with the intention to exclude MTC in patients with basal calcitonin in the gray zone (i.e., 10–100 pg/mL) and detect a residual response after surgery which indicates the need for additional, more aggressive, reinterventions. Here, CALCA is linked to medullary thyroid gland carcinoma.